who makes glp-1 drugs Comparing Ozempic, Wegovy and Other GLP-1 Drugs Could Raise the
Description
2022 Feb 25;32:121-129

1.42% vs

GLP3 is not an official drug class

Cai HY, Hlscher C, Yue XH, et al

Alternative mechanisms by which GLP-1 receptor stimulation may decrease alcohol intake have yet to be thoroughly explored

The therapeutic potential of GLP-1 is limited by its rapid degradation by the enzyme dipeptidyl peptidase-4 (DPP-4)
